Home » Woodcock: Delayed Biosimilars Guidances Imminent
Woodcock: Delayed Biosimilars Guidances Imminent
The first guidances on an abbreviated approval pathway for biosimilars are still in high-level clearance but should be published soon, CDER Director Janet Woodcock tells DID.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May